Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil Lou

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic AdenocarcinomaBach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary reportNicolas Girard, Emil Lou, Christopher G Azzoli, et al.
The Journal of Biological Chemistry|May 13, 2020
<i>RAS</i> internal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signalingAndrew C Nelson, Thomas J Turbyville, Srisathiyanarayanan Dharmaiah, et al.
STAR Protocols|January 10, 2025
Protocol for applying Tumor Treating Fields in mouse models of cancer using the inovivo systemTravis J Gates, Sewar Zbidat, Karina Deniz, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2026
Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapyMilan Radovich, James Wacker, Jeffrey Solzak, et al.
BMJ Oncology|January 31, 2025
Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinomaKhalil Choucair, Andrew Elliott, Matthew James Oberley, et al.
JCO Precision Oncology|May 9, 2024
Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic TargetsErik B Faber, Harris B Krause, Khalid Amin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Evidence for Unified Assessment Criteria of HER2 Immunohistochemistry in Colorectal CarcinomaMark G Evans, Harris B Krause, Joanne Xiu, et al.
Experimental Cell Research|January 29, 2014
Tumor exosomes induce tunneling nanotubes in lipid raft-enriched regions of human mesothelioma cellsVenugopal Thayanithy, Victor Babatunde, Elizabeth L Dickson, et al.
Communications Biology|January 24, 2026
CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpointsFlorencia Cano, Alberto Bravo-Blas, Mathilde Colombe, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic AdenocarcinomaBach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary reportNicolas Girard, Emil Lou, Christopher G Azzoli, et al.
The Journal of Biological Chemistry|May 13, 2020
<i>RAS</i> internal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signalingAndrew C Nelson, Thomas J Turbyville, Srisathiyanarayanan Dharmaiah, et al.
STAR Protocols|January 10, 2025
Protocol for applying Tumor Treating Fields in mouse models of cancer using the inovivo systemTravis J Gates, Sewar Zbidat, Karina Deniz, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2026
Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapyMilan Radovich, James Wacker, Jeffrey Solzak, et al.
BMJ Oncology|January 31, 2025
Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinomaKhalil Choucair, Andrew Elliott, Matthew James Oberley, et al.
JCO Precision Oncology|May 9, 2024
Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic TargetsErik B Faber, Harris B Krause, Khalid Amin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Evidence for Unified Assessment Criteria of HER2 Immunohistochemistry in Colorectal CarcinomaMark G Evans, Harris B Krause, Joanne Xiu, et al.
Experimental Cell Research|January 29, 2014
Tumor exosomes induce tunneling nanotubes in lipid raft-enriched regions of human mesothelioma cellsVenugopal Thayanithy, Victor Babatunde, Elizabeth L Dickson, et al.
Communications Biology|January 24, 2026
CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpointsFlorencia Cano, Alberto Bravo-Blas, Mathilde Colombe, et al.
Pageof 19